2014
Prognostic Implications of Initial Echocardiographic Findings in Adolescents and Adults with Supracristal Ventricular Septal Defects
Cho M, Jang S, Sun B, Jang J, Ahn J, Kim D, Song J, Kang D, Song J. Prognostic Implications of Initial Echocardiographic Findings in Adolescents and Adults with Supracristal Ventricular Septal Defects. Journal Of The American Society Of Echocardiography 2014, 27: 965-971. PMID: 24996557, DOI: 10.1016/j.echo.2014.05.016.Peer-Reviewed Original ResearchConceptsSupracristal ventricular septal defectVentricular septal defectOverall survival rateAortic regurgitationGroup 1Septal defectSurvival rateValsalva ruptureGroup 2High-risk echocardiographic featuresProgression-free survival ratesPerimembranous ventricular septal defectEvent-free rateInitial echocardiographic findingsSevere aortic regurgitationRetrospective observational studySinus of ValsalvaMain clinical eventsAR progressionEchocardiographic featuresEchocardiographic findingsHeart failurePediatric patientsPrognostic implicationsClinical events
2013
Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial
Jang S, Park D, Kim W, Kim Y, Yun S, Kang S, Lee S, Lee C, Park S, Park S. Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial. Catheterization And Cardiovascular Interventions 2013, 81: 1106-1114. PMID: 22899589, DOI: 10.1002/ccd.24603.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiovascular AgentsChi-Square DistributionCoronary AngiographyCoronary Artery DiseaseCoronary ThrombosisDiabetes MellitusDrug-Eluting StentsFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMyocardial InfarctionPaclitaxelPercutaneous Coronary InterventionProportional Hazards ModelsProspective StudiesProsthesis DesignRepublic of KoreaRisk AssessmentRisk FactorsSirolimusTime FactorsTreatment OutcomeConceptsMajor adverse cardiac eventsPaclitaxel-eluting stentsZotarolimus-eluting stentsSirolimus-eluting stentsNondiabetic patientsDiabetic statusDiabetic patientsStent typeIschemia-driven target vessel revascularizationDifferential long-term outcomesLower ratesAdverse cardiac eventsComposite of deathTarget vessel revascularizationLong-term outcomesDifferential treatment effectsSimilar ratesAngiographic characteristicsIschemic complicationsCardiac eventsDiabetes mellitusPrimary outcomeMACE occurrenceStent groupMyocardial infarction